Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Marysville
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Marysville, WA

Studies commonly pay $75 to $4,500 per completed study

196 clinical trials are currently recruiting participants within 30 miles of Marysville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

196studies recruiting
7+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Marysville right now

Top 25 of 196 recruiting studies, sorted by proximity — each links to its official registry page

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Carcinoma, Non-small-Cell Lung Phase 2 Interventional 520 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT05498428)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Parkinson Disease Phase 2 Interventional 150 participants sought
EvergreenHealth (Site #219) — Kirkland, Washington (27.7 mi) · Sponsor: Appello Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07432958)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm Phase 2 Interventional 70 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06126276)

Adapting a Brief Suicide Intervention for Pediatric Primary Care: Enhancing Uptake and Impact

Suicide Prevention N/A Interventional 48 participants sought
Richmond Pediatrics — Mountlake Terrace, Washington (21.4 mi) · Sponsor: University of Washington
See eligibility & contact on ClinicalTrials.gov (NCT06499740)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT02734537)

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

Bipolar I Disorder, Bipolar II Disorder Phase 2 Interventional 195 participants sought
Core Clinical Research /ID# 272955 — Everett, Washington (7.4 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06696755)

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Malignancy N/A Observational 240 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04242095)

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NonSegmental Vitiligo Phase 3 Interventional 180 participants sought
Frontier Dermatology — Mill Creek, Washington (15.4 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06548360)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia Phase 3 Interventional 303 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT03150693)

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

Atopic Dermatitis N/A Observational 1,000 participants sought
Frontier Dermatology Partners CRO LLC- Site Number : 8400011 — Mill Creek, Washington (15.4 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT07290803)

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Urothelial Cancer, Advanced/Metastatic Urothelial Cancer Phase 1, Phase 2 Interventional 132 participants sought
Eye Associates Northwest - Edmonds Clinic — Edmonds, Washington (21.3 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07421700)

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia Phase 2 Interventional 92 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04840602)

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Major Depressive Disorder (MDD), Depression in Adults Phase 3 Interventional 330 participants sought
Core Clinical Research — Everett, Washington (7.4 mi) · Sponsor: Cybin IRL Limited
See eligibility & contact on ClinicalTrials.gov (NCT06793397)

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 700 participants sought
Swedish Cancer Institute - Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06890598)

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma Phase 2 Interventional 81 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05112601)

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Colorectal Cancer Stage II, Colorectal Cancer Stage III Phase 3 Interventional 1,057 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT07018869)

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

COVID-19 SARS-CoV-2 Infection Phase 3 Interventional 2,330 participants sought
Eastside Research Associates — Redmond, Washington (28.2 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06679140)

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine

Episodic Migraine Phase 3 Interventional 990 participants sought
EvergreenHealth Research Department, Merz Investigational Site #0010516 — Kirkland, Washington (27.7 mi) · Sponsor: Merz Therapeutics GmbH
See eligibility & contact on ClinicalTrials.gov (NCT07018700)
Actively enrolling

Studies you may be able to join near Marysville

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for cirrhosis caused by MASH

Enrolling adults aged 18 to 80 with a physician diagnosis of liver cirrhosis caused by MASH (metabolic dysfunction-associated steatohepatitis). Not open to people with treated ascites, variceal bleeding, hepatitis B or C, or alcohol-related liver disease.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Marysville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Core Clinical Research

★ 4.2
2918 Colby Ave, Everett, WA 98201
(425) 443-9551
"I appreciate everyone on the team here, the staff was very kind and welcoming, quiet environment. Very thorough process, but pretty easy!"
— Drake Thompson, 5★

Northwest Clinical Research Center

★ 3.9
1951 152nd Pl NE #200, Bellevue, WA 98007
(425) 453-0404
"Great staff and awesome research studies."
— Linda Martinez, 5★

Providence Everett Center for Clinical Research

★ 1.0
1330 Rockefeller Ave Ste 440, Everett, WA 98201
(425) 261-4069

Clinical Research: Western Washington Medical Group

★ 5.0
12728 19th Ave SE Ste 300, Everett, WA 98208
(425) 225-2760

Rainier Clinical Research Center

★ 4.3
800 SW 39th St Ste 110, Renton, WA 98057
(425) 251-1720
"I have been participating in Type 1 Diabetes studies at Rainier Clinical for at least 15 years and until recently have been impressed with the manage…"
— Annalise k, 3★

Seattle Clinical Research Center

★ 5.0
633 Yesler Wy, Seattle, WA 98104
(206) 522-3330
"I have been part of a vaccine trial here and the staff are so kind. I have a lot of medical anxiety due to some poor experiences. Typically, being in…"
— Kamla Anand Corder, 5★

Clinical Research Center at Minor

★ 4.7
820 Minor Ave N, Seattle, WA 98109
(206) 667-7100
"Wonderful staff, supportive environment"
— Susan Mausshardt, 5★

Clinical trials in Marysville: what's recruiting

The Marysville area currently has 196 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Marysville, the most active research areas are:

  • Cancer & Oncology12 studies
  • Brain & Mental Health4 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Marysville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Marysville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Marysville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Marysville pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Marysville safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Marysville, WA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Marysville typically complete one or two studies per year.

Paid clinical trials near Marysville

Other metros within reach

Bellevue, WA1,519 Seattle, WA1,511 Bremerton, WA1,486 Tacoma, WA1,465 Olympia, WA234 Vancouver, WA1,027 Portland, OR1,027 Salem, OR116

By condition

Eligibility and exclusions, condition by condition

MASH (cirrhosis due to MASH) in Marysville Bladder Issues Due To Spinal Cord Injury in Marysville All conditions

More of WA

Bellevue1,519 Seattle1,511 Bremerton1,486 Tacoma1,465 Vancouver1,027 Spokane287 Olympia234 Kennewick55

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts